Medical Plastics 2020 Global Market Overview

Medical Plastics: The growth of plastics in medical devices has transformed the marketplace, with plastic medical devices steadily replacing other materials such as glass, ceramics, and metals, wherever applicable.

Medical plastics are widely used in medical devices like disposable syringes, intravenous blood bags, optical and dental products, MRIs, heart valves, contact lenses, prosthetic devices, and many more medical products. Medical-grade plastics are used more and more in medical devices for their high performance, lightweight, and lower costs.

During Covid-19 outbreak, increased requirements of Personal Protective Equipment (PPE) will boost the consumption of standard plastics such as medical-grade polypropylene, polyethylene, and drive market demand. Other prominent medical-grade plastics include medical-grade PVC and HDPE medical grade. The overall global market for Medical Plastics is expected to reach US$28 billion in 2020.

Research Findings & Coverage

  • This global market research report on Medical Plastics analyzes the market with respect to product types and applications
  • Medical Plastics market size is estimated in this report by product types and application across all major regions/countries
  • Rapid Rise in the Demand for Medical Plastics in Ventilators amid COVID-19 Pandemic
  • Graphite Nanoplatelets on Plastic Medical Devices Kill 99.99% of Bacteria
  • Plastic Collimators to Replace Metal Collimators
  • Novel Plastic Sensor to Monitor Neurodegenerative Diseases
  • Key business trends focusing on product innovations/developments, M&As, JVs, and other recent industry developments
  • Major companies profiled – 30
  • The industry guide includes the contact details for 134 companies

Key Topics Covered:

PART A: GLOBAL MARKET PERSPECTIVE

1. INTRODUCTION

2. KEY MARKET TRENDS

2.1 Rapid Rise in the Demand for Medical Plastics in Ventilators amid COVID-19 Pandemic

2.2 Plastic Industry, an Essential during COVID-19 Outbreak

2.3 Graphite Nanoplatelets on Plastic Medical Devices Kill 99.99% of Bacteria

2.4 Plastic Collimators to Replace Metal Collimators

2.5 Novel Plastic Sensor to Monitor Neurodegenerative Diseases

3. KEY GLOBAL PLAYERS

  • Arkema S.A. (France)
  • BASF SE (Germany)
  • Celanese Corporation (United States)
  • Covestro AG (Germany)
  • Dupont De Nemours Inc. (United States)
  • Evonik Industries AG (Germany)
  • Exxon Mobil Corporation (United States)
  • Royal DSM (Netherlands)
  • SABIC (Saudi Arabia)
  • Solvay SA (Belgium)
  • The Lubrizol Corporation (United States)
  • Wacker Chemie AG (Germany)

4. KEY BUSINESS AND PRODUCT TRENDS

  • The Ensinger Group Uses PET-GAG Plastic to Make Face Shields
  • PolyOne Unveils ECCOH LSFOH Polymer Grades
  • PolyOne Expands in North America
  • Rotuba and Eastman Agree to Make Cellulose-acetate Based Face Shields
  • Evonik Unveils implant-grade PEEK Filament for Medical Use
  • PolyOne Develops New Bergamid Laser Weldable Material
  • Celanese Corporation Acquires Polymer Business from Nouryon
  • ExxonMobil Expands Polypropylene Production Capacity
  • Rchling Group Supplies Thermoplastic Materials and Components
  • BASF SE and Fabbri Group Develop Compostable Cling Film
  • Evonik Introduce Bioresorbable Polymer
  • DSM Establish High Performance Material Plant in North America
  • PolyOne Showcases Thermoplastic Solutions at MD&M West 2020, California
  • SABIC Launches LNP ELCRES CRX Polycarbonate (PC) Copolymers
  • Trinseo S.A Unveils High Lubricity Polycarbonate (PC)
  • Eastman Develops New Polymers at MD&M West Expo
  • Tekni-Plex, Inc Establish Tekni-Plex Medical business
  • Arkema Presents Polyolefins at K 2019 in Dsseldorf, Germany
  • Trinseo SA and Fernholz Develop High Quality Recycled Polystyrene
  • Evonik Develops New Thermoplastic Elastomers Based on Innovative Copolyesters
  • Nexeo and DSM Enter into Distribution Agreement
  • SABIC Develops NORYL WM330G Resin
  • PolyOne Launches reSound OM Thermoplastic Elastomers (TPE)
  • Solvay Set-up Two New Thermoplastic Composites Centers
  • Evonik Acquires Endexo Surface Modification Business from Interface Biologics, Inc
  • Lanxess AG Commence New High-Performance Plastics Center in China
  • Solvay Establish New Thermoplastic Composite Facility in California
  • BASF, Solvay and DOMO Acquire Polyamide Business
  • RTP Acquires Zeotherm TPV Product Line from Zeon
  • Wacker Unveils Silicone Additive for Thermoplastic Polyurethanes (TPU)
  • SIBUR and BASF Develop Polymer Solutions
  • Evonik and EAS Collaborate on Thermoplastics Portfolio
  • MCAM Acquires APT Corp
  • BASF SE Set-up New Thermoplastic Polyurethanes and Engineering Plastics at Verbund Site in Zhanjiang, China
  • DuPont Develops Polyamide Grades
  • Trinseo SA Presents TPEs at the Healthcare Elastomer Conference from May 21-22 in Schaumburg, Illinois, USA
  • Celanese Expands in Italy
  • Covestro Develops Makrolon Rx2235 Polycarbonate
  • The Ensinger Group Acquires Moll Engineering GmbH
  • Celanese Buys Next Polymers Ltd
  • RTP Showcases Thermoplastic Products
  • Evonik Signs Distribution Agreement with CSL
  • Covestro A.G Raise Stakes in DCP
  • KOLON BASF Establish Polyoxymethylene (POM) Center in South Korea
  • Covestro Develops Polyether Carbonate Polyols
  • Evonik Unveils CYROLITE High Performance Acrylic-Based Polymers
  • LANXESS Expands its Thermoplastic Composites Business in Germany
  • QS And Covestro AG Develop Makrolon Medical-Grade Polycarbonates Injection
  • The Ensinger Group Launches Polyacetal Copolymer (POM-C)
  • BASF Acquires Advanc3D Materials GmbH
  • SABIC Unveils New Thermoplastic Solutions
  • SABIC Showcases high-Performance Thermoplastic Solutions
  • Covestro AG Begin Composite materials Production
  • SABIC Unveils UDMAX Thermoplastic Composite Tape
  • Celanese Acquires Omni Plastics LLC
  • PolyOne and ITI Collaborate to Commercialize ElectriPlast Material
  • PolyOne Expands in India
  • PolyOne’s COMPTEK Medical-grade Polymers in North America
  • SABIC Begins Polyacetal Production

5. GLOBAL MARKET OVERVIEW

PART B: REGIONAL MARKET PERSPECTIVE

REGIONAL MARKET OVERVIEW

6. NORTH AMERICA

7. EUROPE

8. ASIA-PACIFIC

9. SOUTH AMERICA

10. REST OF WORLD

PART C: GUIDE TO THE INDUSTRY

1. North America

2. Europe

3. Asia-Pacific

4. Rest of World

PART D: ANNEXURE

1. Research Methodology

2. Feedback

For more information about this report visit here.

Hot this week

Cartessa Aesthetics Partners with Classys to Bring EVERESSE to the U.S. Market

Classys, which is listed on the KOSDAQ, is one of South Korea's most distinguished aesthetic technology manufacturers, with devices distributed in 80+ markets globally. This partnership marks Classys's official entry into the American marketplace, with Cartessa Aesthetics as the exclusive distributor for EVERESSE, launched under the Volnewmer brand in current global markets.

Stryker Launches Next-Generation of SurgiCount+

Now integrated with Stryker's Triton technology, SurgiCount+ addresses two key challenges: retained surgical sponges and blood loss assessment. Integrating these previously separate digital solutions provides the added benefit of a more efficient, streamlined workflow for hospitals notes Stryker.

Nevro Receives CE Mark In Europe for It’s HFX iQ™ Spinal Cord Stimulation System

Nevro notes HFX iQ is the first and only SCS system with artificial intelligence (AI) technology that combines high-frequency (10 kHz) therapy built on landmark evidence that uses ongoing cloud data insights to deliver personalized pain relief

Recor Medical Reports: CMS Grants Distinct TPT Device Code and Category to Recor Medical for Ultrasound Renal Denervation

The approval of TPT offers incremental reimbursement payments for outpatient procedures performed with ultrasound renal denervation for Medicare fee-for-service beneficiaries. It becomes effective January 1, 2025, and is expected to remain effective for up to three years notes Recor Medical.

Jupiter Endovascular Reports | 1st U.S. Patient Treated with Jupiter Shape-shifting Thrombectomy Device

“Navigation challenges during endovascular procedures are often underappreciated and have led to under-adoption of life-saving procedures, such as pulmonary embolectomy. We have purpose-built our Endoportal Control technology to solve these issues and make important endovascular procedures accessible to more clinicians and their patients who can benefit from them,” said Carl J. St. Bernard, Jupiter Endovascular CEO. “This first case in the U.S. could not have gone better, and appears to validate the safety and performance we are seeing in our currently-enrolling European SPIRARE I study.”
Exit mobile version